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Observation of metastable Ap amyloid protofibrils by atomic 
force microscopy 
James D Harper’!*, Stanislaus S Wong3, Charles M Lieber3 and 
Peter T Lansbury, Jr2 
Background: Brain smyloid plaque, a diagnostic feature of Alzheimer’s disease 
(AD), contains an insoluble fibrillar core that is composed primarily of variants of 
the P-amyloid protein (A@. As Ap smyloid fibrils may initiate neurodegeneration, 
the inhibition of fibril formation is a possible therapeutic strategy. Very little is 
known about the early steps of the process, however. 
Results: Atomic force microscopy was used to follow amyloid fibril formation 
in V&O by the Ap variants Apl-40 and A@1 -42. Both variants first form small 
ordered aggregates that grow slowly and then rapidly disappear, while 
prototypical smyloid fibrils of two discrete morphologies appear. API-42 
aggregates much more rapidly than Apl-40, which is consistent with its 
connection to early-onset AD. We propose that the met&able intermediate 
species be called Ap amyloid protofibrils. 
Conclusions: Ap protofibrils are likely to be intermediates in the in vitro 
assembly of AD smyloid fibrils, but their in viva role has yet to be determined. 
Numerous reports of a nonfibrillar form of AD aggregate in the brains of 
individuals who are predisposed to AD suggest the existence of a precursor 
form, possibly the protofibril. Thus. stabilization of Al3 protofibrils may be a useful 
therapeutic strategy 
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introduction 
Alzheimer’s disease (AD) is cbaracrcrized by the presence 
of neuritic plaque in the brain. The insoluble core of neu- 
ritic plaque contains amyloid tibrils comprising variants of 
the -4.kDa P-amyloid protein CAP; Fig. 1) [l]. Three lines 
of evidence suggest that amyloid tibril formation causes 
“curodegeneration. First, tibrils comprising synthetic AD 
are toxic to neuronal cultures, whereas soluble, presumably 
monomeric, A@ and amorphous AP aggregates have no 
activity [Z]. Second, insoluble AP aggregates of undcter- 
mined morphology activate microglia in culture [31. Finally, 
transgcnic mice overexpressing AD and its precursor, APP, 
develop AD pathology, including amyloid plaques, as well 
as learning and memory deficits over time (the relative 
timing of the parhological a”d behavioral changes has yet co 
be determined) [4]. These and numerous other studies 
suggest that the inhibition of amyloid formation would be’ 
an excellent therapeutic strategy against AD. But for this to 
be successful a” understanding of the detailed molecular 
mechanism of AP amyloid iibril formation would be 
extremely useful. 
A@ amyloid iibrillogenesis appears to be rate-limited 
in eritm by the requirement for the formation of a” ordered 
AP nucleus [5,6]. Studies of the predominant circulating 
variant of A$, Apl-40, and the carboxy-terminally- 
extended variant API-42 (Fig. I) showed rhat API-42 
nucleated much more rapidly than ApI- [71. This obser- 
va:io” led to the proposal that cariy-onscr familial AD 
(FAD) may resulr from abnormally rapid amyloid forma- 
tion due to a” increase in the rafio of Apl-42 to Apl-40 
171. Evidence supporting this proposal has accumul&cd. 
For example, the plasma of FAD patients contains a higher 
ratio of APl-42 to A@l-40 than age-marched conrrols [Xl. 
In addition, cultured cells expressing FAD-mutant forms 
of t-ither of two proteins (APP or presenilin) overexpress 
API&42 [9-111. Ncuropathological studies of FAD patients 
show a parallel trend [12,13]. Finally, transgenic mice 
expressing FAD mutations produce higher levels of 
Apl-42 relative to API-40 tha” control mice lacking the 
transgene [4,10,11,14]. 
The mechanistic model of amyloid formatio” as a nuclc- 
ation-dependent polymerization offers a plausible expla- 
nation for FAD. However, the details of the in V&I 
mechanism have not been elucidated, due to two signifi- 
cant experimental problems. First, the methods used to 
measure amyloid, primarily mrbidometry and sedimenra- 
Con, do not necessarily distinguish between fibrillar 
morphologies, so a single product morphology has been 
tacitly assumed. Second, these two methods are unable to 
detect small AP oligomers, so the early steps of the assem- 
bly process have not been elucidated. Small oligomeric Afi 
species have been separated and/or detected by three 
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Sequences of the two Ap variants A@1 -40 and Api -42. 
methods: analytical ultraccntrifugation - Apl-40 (at 
45Op,M) produces a slowly sedimenring species (proposed 
to contain -1000 API-40 molecules), which was observed 
in addition to the rapidly scdimenting, probably fibrillar, 
material [lSI; gel filtration chromatography - both 
APl40 and AP1-U (at 22Ow.M) wcrc observed to produce 
a slowly~sedimcnting species (estimated by gel filtration 
chromatography to bc >lOOkDa [161; and dynamic light 
scattering - under acidic conditions, an oligomcric 
Apl-40 species, proposed to be a micellc (critical conccn- 
trdtion in O.lN HCI= loo@), was rapidly formed [17]. 
The methods used are not capable of providing dctailcd 
structural information. 
Atomic force microscopy (AFM) is an idcal tool fo follow 
the early events of Ap amyloid fibril assembly because it is 
capable of directly detecting and measuring the dimen- 
sions of small proteinaccous species that arc adsorbed from 
aqueous media (Fig. 2) [l&191. Previous AFM studies of 
HP amyioid did not foilow the process of tihril formation, 
but focussed on a single time point, after long incubations 
of concentrated solutions of Apl-40 (25OkM) [ZO]. We 
chose to follow incubations slightly in excess of the critical 
concentration for amyloid formation ([APlAO] =45 PM, 
[AplX?]=XIfiM) [Zll, on the grounds that these condi- 
tions closely approximate those under which amyloid for- 
mation is likely to occur in most types of AD. In addition, 
multiple time points were analyzed in order to obtain 
information about the mechanism of tibril formation. 
Results 
Rapid formation of discrete protofibrils by Apl-40 
At intervals, Apl-40 solutions were gently agitated to 
evenly suspend any aggregates before aliquots were 
removed from the otherwise undisturbed solutions and 
the structural properties of the AP species adsorbed 
onto mica were analyzed by AFM. Small elongated AD 
oligomers, termed ‘protofibrils’, became visible during the 
first week of incubation (Fig. 3). The early protofibrils had 
diameters, inferred from the heights of the topographs 
(see later) [lH,191 of 3.liO.31 nm and lengths in the range 
20-70 nm. As shown in Figures 3 and 4 (green ?rrows), the 
protofibrils elongated over three weeks while retaining a 
constant diameter (the measured heights will be rcfcrred 
to as diameters here, although the cross-section may not 
Position-sensitive 
detector ---- 
AFM measures the deflection of a sensitive cantilever with a silicon 
probe tip as a sample adsorbed onto a smooth substrate (e.g. mica) is 
rastered underneath. The inset shows a schematic of the tip-surface 
interaction, which demonstrates that the height of an object above the 
surface can be determined. but that dimension in the plane of the 
image (WI is difficult to measure accurately. due to the shape and the 
finite size oi the tip. The overestimation of width is related to the height 
and the true width of the feature and the shape ai the 1 O-20 nm 
diameter silicon tip. which is difficult to determine accurately [I 8,191. If 
should be noted that the elasticity of the features is important in the 
measurement of apparent height L18.191. The upper portion of the 
diagram is courtesy of Digital Instruments. Santa Barbara, CA. 
be circular) reaching lengths often exceeding 100 nm. A 
parallel incubation at much higher Apl-40 concentration 
(200pM) developed protofibrils of similar lcngrh in two 
days, and these protofibrils were stable for more than two 
weeks after dilution co 20pM (data not shown). Tht: 
protofibrils oftcn showed small regular variations in diam- 
ctcr with B pcriodicity of ZOk4.7 run (see green arrow in 
Figure 4). The small size of these prorofibrils preclude 
their observation by turbidity 17,211. 
Formation of type-l and type-2 fibrils 
After four weeks of incubation, long (> 1 km) Apl-40 
fibrillar species (designated type l-fib&) of at lcast 
twice the diameter of the protofibril (7.8f0.45nm) and 
characrerizcd by a periodic modulation in diameter 
(pcriod=43*0.50 nm) appeared (Figs 3,4, red arrows). 
Strikingly, short (~500nm) type-l fibrils wcrc rarely seen. 
After five weeks, the protofibrils had disappeared 
completely and a second tibril type (type-2 iibril, diame- 
ter=4.5t0.43nm) appeared (yellow arrows). Further 
studies arc required in order to determine if the type-2 
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Figure 3 
Represent&e 2 p.m square AFM images of the time course of fibril 
formation by ADI -40 (at 45 (LM, top row) and A@1 -42 (at 20 FM, 
bottom row). !n each image, the mica surface appea:s dark brown, 
and the brightness of the features increases as a function of their 
height (for example, the ieatures shown in the 4 day Apl-42 image 
appear brighter than the analogous features in the 3 week ApI -40 
image because they are higher (vide infra); in addition, the very 
bright features in the early images are probably large amorphous 
aggregates). For both API-40 and ADI-42, the progression 
from small protofibrils (green arrows) to longer pratofibrils (also 
green arrows) !c fibrils of two types (typo ! =icd, type 2=yellaw: 
is clear. as is the absence of protofibriis at the latest time points. It 
is also clear that the progression from protofibrils to fibrils occurs 
more rapidly for ApI -42, despite the fact that protein 
concentration is lower, am&tent with the conclusion based on‘ 
turbidometric methods VI. 
tihril, which appears lacer in the AD140 incubation, is the 
thermodynamic product. The diameter of type-l Apl-40 
tihrils resembled API40 fib& formed GJ wit/-u [ZZ] and 
amyloid fib& derived from AD brain (width of -8nm 
inferred from electron microscope images; D. Sclkoe, 
personal communication). 
Rapid assembly of Apl-42 
Amyloid fibril formation by!@-42 followed a similar, hut 
xx&rated, time coux to Apl-40 [71 despite the fact 
that the AB1-42 concentrntion was, as if is in tG.v [Xj, sig- 
nificantly lower (2O~M)than Apl-40 (45p,M). Protofihrils 
formed within the first day of incubation and ‘elongated 
over time (Fig. 3). Long (almost always > 1 pm, usually 
>Sym) Apl-42 type-l and type-2 fib& were detected 
after 8 days of incubation and all prototibrils had disap- 
peared by 11 days. The observed kinetic diffcrenccs 
between A@142 sod Apl-40, which arc consistent with 
turbidometric studies, support the proposal that elevated 
levels of APl-42 lead to mote rapid amyloid formation in 
FAD [7]. This scenario has been supported by numerous 
studies of thr lcvcls of APl-42 and Apl-40 in the plasma 
and brain tissue of FAD patients and in the culture media 
of cells stably transfecred with FAD mutant gene products 
(see above). 
Dimensions of Apl-42 and Apl-40 oligomets 
The measured diameter of the Apl-4Z-derived species 
diffcrcd from the analogous Apl-40 species (Fig. 5). The 
Apl-42 protofihrils had a larger diameter (4.2?r0.58nm) 
than the Apl-40 protofibrils, but a similar periodicity 
(ZZiXlnm). Like Apl-40, two types of fihrils~were 
detected; periodic type-l fibrils (7.3 +O.S3 nm, -43 nm 
period) and type-2 fihrils (3.8~0.43 nm). The difference 
in diameter between the Apl-42 and Apl-40 protofib- 
rils could be explained by the fact that the structural 




Representative 1 wm square images of three distinct Api -40 
aggregate morphalogies (API-M species have a similar appearance, 
Fig. 3). Areas of increasing brightness in each image correspond to 
areas of greater height. The relative height SC&S of each image were 
chosen to maximize contrast in the features of interest. so height 
comparisons between images should not be made. (a) A field of 
protofibrils with green arrows pointing to peaks bordering two clearly 
defined periodic height modulations (- 4Onm) along the long axis of 
Figure 5 
the protofibrils. Bright features correspond to crossed protofibrils. 
(b) Type-l fibrils are indicated (protafibrils can also be seen) with red 
arrows marking peaks bordering two periods on a type-l fibril 
(- 8Onm). The helical nature of the periodic modulations is clear. 
(c)Type-S fibrils are clearly distinct from both protofibrils and type-l 
fib&. Although they lack the regular height increases which characterize 
both protafibrile and type-l fib& they do show lese regular 
discontinuities (yellow arrows) et irregular intervals often >t 00 nm. 
The dimensions of the six distinct species (protofibrils, type-l fibrils, three repeats are difficult to obtain. Note that the vertical axee are all at 
and type-2 fib& comprising Apl-40 (top) and A(31 -42 (bottom)). the eame scale, whereas the horizontal scales vary. Cursors are set to 
The tap row correspoods to the images in Figure 4. In each panel, axial indicate two periods in the axial sections and to show the cross 
sections are at the top and cross sections at the bottom. Due to the section of the species of interest. Vertical axes for all plots: height 
nonlinear nature of these species. axial sections showing more than (nm). Horizontal axes for all plots: horizontal distance (nm). 
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Discussion 
A scenario in which A@ protofibrils are intermediates in 
the assembly of the AD-amyloid fibril (Fig. 6) is supported 
by the fact that the disappearance of protofibrils occurs 
over a shorter time period than protofibril elongation and 
is concurrent with the appearance of fibrils. Several addi- 
tional observations are pertinent to discussions of the 
probable mechanism. First, protofibril elongation is much 
slower than fibril elongation. The scarcity of small fibrils 
suggests that once tibrils are nucleated, their growth is 
rapid and favorable [6,7]. Second, the diameters of the 
AD140 protofibrils and the A(31-40 fibrils (both types) are 
clearly different, which precludes a simple end-to-end 
protofibril association mechanism. In the case of Afil-42, 
however, the type-2 fibrils (but not the type-l tibrils) have 
a similar diameter to the protofibril, so a linear association 
mechanism can~not be ruled out. Third, the cxistcnce of 
an apparent threshold protofibril length b&xc fibrils 
appear suggests that a minimal overlap between protofib- 
rils may be required to stabilize B structure in which two or 
more protofibrils wrap around one another. Thus, the fibril 
diameter may result from TWO or more protofibrillar sub- 
units, analogous to the transthyretin amyloid tibril [25,26]. 
Subunit structure has also been seen by electron micro- 
scopy of analyzed fibrils comprising unnatural AP frag- 
ments [271. Finally, an incubation of AD140 (45 p,M) that 
was not disturbed for seven weeks, but was otherwise 
identical to those described above, contained only 
protofibrils, suggesting that an enhanced frequency of 
protofibril-protofibril encounters in agitated solutions pro- 
motes fibril formation, Alt~hough the direct precursor mech- 
anism is attractive, we have not ruled out the possibility 
Figure 6 
A mods! for AP-fibril assembly. based on the images presented in 
Figures 3 and 4. Whether the protofibrils are assembly precursors of the 
fibrils or whether the protofibrils are in fast equilibrium with monomer, 
which slowly reassembles to type-l and type4 fibriis. has not been 
determined (? in Figure), although suggestive evidence for the former 
relationship is presented in the text. In addition, it is not clear whether the 
type-l or the type-2 fibril. or another species, is the most stable product. 
It must be emphasized that species which do not absorb onto mica are 
not seen by this method. However, preliminary experiments using a 
hydrophobic graphite swface (HOPG) show the same species and no 
additional ones. In addition, since the velocities of the individual steps 
may have different concentration-dependencies. it is conceivable that the 
lifetimes of these species may be altered at lower or higher [API or that 
new species become apparent. The protofibril+a-fibril transition seems to 
be the best candidate for the nucleation-dependent step [6,71. because 
pratofibrils apparently must reach a certain length and/or concentration 
before rapid fibril growth occurs. Growth of the fibrils. once nucleated, 
may be first order in (ApI [17.31.321. 
that protofibrils are rapidly formed, but are in fast equilib- 
rium with monomeric AP, which slowly assembles into the 
more stable type-l and type-2 iibrils (Fig. 6). We believe 
that this is unlikely, although in either scenario the stabi- 
lization of protofibrils would inhibit fibril formation, either 
by blocking protofibril-protofibril, interactions or by 
slowing the protofibril-monomer equilibrium. 
Although there is no direct evidence presently available 
for the transient existence of AD protofibrils in viva, an 
apparently nonfibrillar form of deposited A@, termed 
diffuse amyloid plaque, is prevalent in individuals 
known to be predisposed to AD, leading to the proposal 
that it represents an innocuous precursor to neuritic 
amyloid [28]. Diffuse plaque may contain protofibrillar 
AP that is not easily detected by electron microscopy. It 
will be important to study this material by AFM in the 
future. Significantly, AP protofibrils, like diffuse amyloid 
plaques, arc more difficult to sediment than amyloid 
fibrils (Dominic Walsh and David Teplow, personal 
communication). 
The conversion of protofibrillar AP into tibrillar A@ may 
be a critical step in AD pathogenesis. Inhibition of this 
transition, regardless of whether it is a direct conversion or 
occurs via the AD monomer, would inhibit amyloid forma- 
tion. ApoE may inhibit this process by binding protofib- 
rils, as suggested by kinetic [21] and biochemical studies 
[29]. This may explain the correlation between apoE 
genotype and AD susceptihilitylage of onset [30]. It may 
be possible to find an exogenous compound that similarly 
blocks the protofibril-to-fibriI transition. This would bc a 
practical mode of inhibition, since the inhibitor could be 
effective in low concentrations relative to A@. If, as 
suggested by in o&o studies of neurofoxicity and 
microglia activation [2,3], the AP amyloid fibril is responsi- 
ble for initiating AD neuradcgeneration, then the AD 
protofibril should be targeted by drug discovery efforts 
aimed at d&eloping a therapeutic for AD. 
Significance 
The presence of amyloid tihrils, ordered protein nggre- 
gates comprising A$ protein variants, in the brain is a 
defining and unique feature of Alzheimer’s disease 
(AD). Because it is very difficult to reconstruct the in 
vivn pathway based on neurnpatbological d&la, we study 
the in vitro mechanism of AP amyloid formation, on the 
assumption that it may be analogous to the situation in 
AD. In this study, amyloid formation by the two pre- 
dominant AP variants was followed using atomic force 
microscopy (AFM), a relatively new technique which 
allows one to create a nanometer-scale image by physi- 
cally contacting species adsorbed to a smooth surface. In 
both cases, the first-formed species ~8s not the expected 
amyloid iibril, but a smaller species of discrete mor- 
ph+gy. This species slowly elongated, then rapidly 
124 Chemistry & Biology 1997. Vol 4 No 2 
disappeared in favor of typical amyloid fib&. We 
propose to call this metastable intermediate the Ap 
amyloid protofibril, to indicate the possibility that it rep- 
resents a fibril assembly intermediate. The overall 
process was much more rapid in the case of the 
42 amino-acid variant API-42 when compared with the 
h-uncated variant Apl-40, which is the major circulating 
species, consistent with the fact that increased expression 
of the former variant is associated with early-onset AD. 
The existence of n metastable intermediate protoiibril 
offers B possible morphological explanation for the com- 
monly observed diffuse amyloid plaque, an apparently 
innocuous and nonfibrillar form of deposited A@ which 
charncterizes the brains of individuals who are predis- 
posed to AD. III addition, it suggests a potential therapeu- 
tic target, since converging evidence suggests that amyloid 
tibrils may initiate a cascade of events which culminate in 
neuronal death. Stabilization of the protoiibril intermedi- 
ate could inhibit fibril formation, thus delaying the onset 
of neurodegeneration. Finally, there may be endogenous 
proteins (e.g. apoE) which act in a similar way; these 
could be protective factors against AD. 
Materials and methods 
Synthetic Apl-40 was purchased from Qualify Controlled Biochemi- 
tale Inc. (Hopkinton. MA). Synthetic ApI -41 was provided by David 
Teplow of the Center for Neurologic Diseases. 
In vitro fibril formation and sample preparat;oon 
Stock eol”tions of AB1-40 and Afil-42 were made by dissolving 
each pepiida i&l dimeihyi suiioxide (DMSO) at 0.34 mM (Agl-42) or 
O.B4mM (API-40) and, in the case of Apl-40. filtering through Milieu- 
FG 0.22 p,m filters (Miliipore). Final cancentr6tions of the DMSO 
stocks were determined by quantitative amino acid analysis. A&quote of 
the DMSO stock solutions (9 nm~i in - 1 1 &I for ApI -40, 4 nmol in - 
1, p,I for API-4’2) were added to aqueous buffer (200 ~1 total volume, 
100 mM N&I, 1 OmM NaH,PO,, pH 7.4) and immediately vortexed 10 
mix before allowing fibril formation to proceed at worn temperature. 
Atomic force microscopy 
At intervals, otherwise undisturbed aggregation mixtures were mixed by 
gentle tapping and samples were prepared for imaging by transferring 
5 pl of the suspension to the surface ai freshly cleaved mica (Ted Peila 
Inc.. Aedding, CA). AHer 1 min the remaining suspension was remaved 
by absarptian and the substrate was rinsed twice with 50 ~1 water to 
remove salt and loosely bound peptide. Excess water was removed with 
a gentle stream of filtered compressed air and the sample was imaged 
immediately. All images were obtained under ambient conditions with 
a Nanoecope llla MultiMode scanning probe workstation (Digital Instru- 
ments, Santa Barbara, CA) operating in TappingModeTM “sing 120 +m 
etched silicon NewsProbes TM (125p.m cantilever, spring constant 
=20-l OONm-‘, tip redi”s=5-I Onm) (Probe Model TESP, Digital 
Instruments). Scanning parameters varied with individual tips and 
samples, but typical ranges were as follows: starting RMS amplitude. 
2.OV; setpoint. 1.5-1.75X tapping frequency, 250-350 kHz; wan rate, 
0.5-Z Hz. The diameters of features as described here were obtained 
by averaging 30 peak height valuee obtained for the stated morphology 
“sing nanoscope section analysis software (i standard deviation). 
Periodicities were determined by averaging 30 peak-to-peak distances 
(i standard deviation) except for the caee of the AFT-42 type 1 fibril, 
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